Share on LinkedInShare on LinkedIn

ARTICLE · 12 MAY 2026

Building A Future-Proof IP Strategy For AI In Medtech

Greenberg Traurig
Greenberg Traurig
Contributor
Greenberg Traurig

Greenberg Traurig

Greenberg Traurig, LLP has approximately 3,200 lawyers across 51 locations in the United States,...

View firm profile
Explore more from Greenberg Traurig

The healthtech industry is witnessing fierce competition as companies develop AI-powered tools for clinical decision support, robotic surgery, medical imaging, and drug discovery.

WorldwideIntellectual Property
 David J.  Dykeman
David J. Dykeman
Andrew (A.J.) Tibbetts
Andrew (A.J.) Tibbetts
Samuel S. Stone
Samuel S. Stone

The healthtech industry is experiencing intense competition as companies race to develop software and artificial intelligence (AI) tools for clinical decision support, medical telemetry, robotic surgery, surgical navigation, medical imaging analysis, drug discovery, clinical trial management, and countless other medical applications. This competitive landscape is driving substantial investment and rapid innovation, with established medtech providers, disruptive startups, and well-funded tech giants all striving to integrate AI into the medical industry and patient experience. 

LINKS 

Read “Building a Future-Proof IP Strategy for AI in Medtech,” co-authored by David J. Dykeman, Andrew (A.J.) Tibbetts, and Samuel S. Stone, published by Medical Product Outsourcing

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from